Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · IEX Real-Time Price · USD
0.835
-0.060 (-6.67%)
Apr 16, 2024, 4:30 PM EDT - Market closed

Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $60.60 million. The enterprise value is -$64.78 million.

Market Cap 60.60M
Enterprise Value -64.78M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

ALGS has 72.58 million shares outstanding. The number of shares has increased by 50.51% in one year.

Shares Outstanding 72.58M
Shares Change (YoY) +50.51%
Shares Change (QoQ) +47.74%
Owned by Insiders (%) 21.07%
Owned by Institutions (%) 62.52%
Float 36.68M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.85
Forward PS n/a
PB Ratio 0.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.90, with a Debt / Equity ratio of 0.12.

Current Ratio 5.90
Quick Ratio n/a
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 70.90

Financial Efficiency

Return on equity (ROE) is -116.40% and return on invested capital (ROIC) is -85.38%.

Return on Equity (ROE) -116.40%
Return on Assets (ROA) -75.40%
Return on Capital (ROIC) -85.38%
Revenue Per Employee $235,288
Profits Per Employee -$1.33M
Employee Count 66
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

In the past 12 months, ALGS has paid $795,000 in taxes.

Income Tax 795,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.33% in the last 52 weeks. The beta is 2.34, so ALGS's price volatility has been higher than the market average.

Beta (1Y) 2.34
52-Week Price Change -2.33%
50-Day Moving Average 0.88
200-Day Moving Average 0.80
Relative Strength Index (RSI) 43.36
Average Volume (30 Days) 391,704

Short Selling Information

The latest short interest is 868,831, so 1.20% of the outstanding shares have been sold short.

Short Interest 868,831
Short Previous Month 365,600
Short % of Shares Out 1.20%
Short % of Float 2.37%
Short Ratio (days to cover) 1.77

Income Statement

In the last 12 months, ALGS had revenue of $15.53 million and -$87.68 million in losses. Loss per share was -$1.36.

Revenue 15.53M
Gross Profit 15.53M
Operating Income -88.13M
Pretax Income -86.88M
Net Income -87.68M
EBITDA -85.06M
EBIT -88.13M
Loss Per Share -$1.36
Full Income Statement

Balance Sheet

The company has $135.77 million in cash and $11.14 million in debt, giving a net cash position of $124.64 million or $1.72 per share.

Cash & Cash Equivalents 135.77M
Total Debt 11.14M
Net Cash 124.64M
Net Cash Per Share $1.72
Equity / Book Value 92.08M
Book Value Per Share 1.27
Working Capital 117.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.00 million and capital expenditures -$19,000, giving a free cash flow of -$79.02 million.

Operating Cash Flow -79.00M
Capital Expenditures -19,000
Free Cash Flow -79.02M
FCF Per Share -$1.23
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -567.50% and -564.61%.

Gross Margin 100.00%
Operating Margin -567.50%
Pretax Margin -559.50%
Profit Margin -564.61%
EBITDA Margin -547.74%
EBIT Margin -567.50%
FCF Margin -508.83%

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -50.51%
Shareholder Yield -50.51%
Earnings Yield -146.47%
FCF Yield -132.00%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) 84.11%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ALGS has an Altman Z-Score of -4.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.78
Piotroski F-Score 4